Biological availability of oxytetracycline HC1 capsules
Butler, K.
Revue Canadienne de Biologie 32(Suppl): 53-67
1973
ISSN/ISBN: 0035-0915 PMID: 4777603 Document Number: 62982
Document emailed within 1 workday
Related Documents
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87Sandell, E.; Eriksson, K.; Mellström, G. 1970: A disintegration test for evaluation of drug availability from tablets and capsules Acta Pharmaceutica Suecica 7(5): 559-566
Kowalski, C.; Pomorska, M.łg.; Lebkowska, B.; Sławik, T. 2006: Determination of oxytetracycline in biological matrix Acta Poloniae Pharmaceutica 63(5): 409-411
TerHune, T.N.; Upson, D.W. 1989: Factors affecting the accuracy of the live animal swab test for detecting urine oxytetracycline and predicting oxytetracycline residues in calves Journal of the American Veterinary Medical Association 194(7): 918-921
Hrishi Keshavan, H.J.; Gurbani, N.K.; Batra, V.; Dandiya, P.C.; Sharma, R.G. 1980: Availability of ampicillin in biological fluids Indian Journal of Medical Research 72: 920-922
Shelepova, V.M.; Shashkin, P.N.; Shashkina, M.I.; Skurikhin, V.N.; Dvinskaia, L.M. 1992: Biological availability of beta-carotene Voprosy Meditsinskoi Khimii 38(6): 25-27
Gamski, M.; Lewandowska, J.; Falkowski, L. 1982: Biological availability of hydroxydial (Ipronal "Polfa") Polski Tygodnik Lekarski 37(45): 1363-1364
Alván, G.; Bertler, A.; Eeg-Olofsson, O.; Karlsson, E.; Sjöqvist, F.; Tomson, G. 1975: Biological availability--a comparison between 3 phenytoin preparations Lakartidningen 72(24): 2621-2623
Zaremba, M.; Karpińska, B.; Sobaniec, H.; Kacprzak-Wiatr, A.; Grygiel, J.; Konopiński, P.; Zakrzewska, I.; Czeczuga-Semeniuk, E.; Borowski, J. 1984: Studies on the biological availability of vibramycin in humans Acta Poloniae Pharmaceutica 41(6): 695-701
Luckow, V.; Krammer, R.; Traub, R. 1992: Comparative biological availability of two different ibuprofen granules Arzneimittel-Forschung 42(11): 1339-1342
Kurunmäki, H.; Toivonen, J.; Lähteenmäki, P.; Luukkainen, T. 1985: Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules Contraception 31(3): 305-318
Pla, G.W.; Fritz, J.C.; Rollinson, C.L. 1976: Relationship between the biological availability and solubility rate of reduced iron Journal - Association of Official Analytical Chemists 59(3): 582-583
Sedlmayer, P.; Sispera, L.; Rejholec, V.; Chaura, Z. 1984: Biological availability and pharmacological effects of Prazosin VUFB in dogs Ceskoslovenska Farmacie 33(6): 235-237
Yokono, K. 2002: Rapid-acting insulin analogs--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 480-484
Vinar, O. 1984: Does the biological availability of acetylcholine assure intellectual functioning? Risks of anticholinergics Casopis Lekaru Ceskych 123(40-41): 1246-1247
Rasmussen, I.C.; Odenholt, I.; Raab, Y. 2000: Peroral antibiotic prophylaxis in upper gastrointestinal surgery. a study of biological availability Lakartidningen 97(26-27): 3174-3176
Paczkowski, D.; Sadowski, Z.; Koliński, P.; Filipek, M.; Podleśny, J. 1989: Evaluation of the relative biological availability of amiodarone Polfa preparation after extravascular administration of a single dose Kardiologia Polska 32(6): 326-333
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z. 1985: Comparison of the biological availability of retard and non-retard lisuride tablets in dogs Ceskoslovenska Farmacie 34(1): 3-6
Ipsen, J. 1971: Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong) Current Therapeutic Research 13(3): 193-208
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582